Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesRecurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features
Child's Nervous System, 10/29/09
Zhang W et al. – Childhood glioblastomas show a distinct biological behavior and probably a different molecular pathogenesis in comparison to the adult ones. Understanding the molecular mechanisms responsible for the formation and progression of the tumors is critical for identification of novel therapeutic targets.
Tao Jiang, 10/30/09
| Childhood glioblastoma multiforme is an uncommon brain tumor. Bevacizumab is a novel antiangiogenic agent, which has been reported recently in recurrent GBM. In this paper, we report a case of childhood GBM treated with bevacizumab and investigate the molecular alterations before and after recurrence. This study has determined, for the first time, the correlations of molecular features with clinical outcomes of childhood GBM treated with bevacizumab. Our findings may also have general implications in the cell biology of gliomas. We strongly believe the contribution of this study warrants its publication in Child's Nervous System. |
Related Articles
Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme
Journal of Neuro-Oncology, 10/28/09
Relevance Score: 88%
Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
Clinical Cancer Research, 10/01/09
Relevance Score: 88%
Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes
Cancer, 11/12/09
Relevance Score: 87%
Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
Clinical Cancer Research, 10/06/09
Relevance Score: 87%
Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme
Journal of Neuro-Oncology, 10/01/09
Relevance Score: 87%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radiosurgical technique
Neurosurgical Focus, 12/17/09
Oxaliplatin-induced Lhermitte's phenomenon as a manifestation of severe generalized neurotoxicity
Oncology (Karger), 12/17/09
Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma
Journal of Neuro-Oncology, 12/17/09
Today in Pediatric Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Lack of Association Between Measles-Mumps-Rubella Vaccination and Autism in Children: A Case-Control Study
The Pediatric Infectious Disease Journal, 12/17/09
Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic—ischaemic encephalopathy: a nested substudy of a randomised controlled trial
The Lancet Neurology, 12/17/09
Predicting school readiness from neurodevelopmental assessments at age 2 years after respiratory distress syndrome in infants born preterm
Developmental Medicine & Child Neurology, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor